Pubdate: Thu, 04 Sep 2014 Source: Sydney Morning Herald (Australia) Copyright: 2014 The Sydney Morning Herald Contact: http://www.smh.com.au/ Details: http://www.mapinc.org/media/441 Author: Nicholas Talley Note: Professor Nicholas Talley is president of the Royal Australian College of Physicians. Page: 20 A DOCTOR'S DILEMMA ON MEDICINAL MARIJUANA In recent weeks we have seen the political landscape shifting rapidly as moves to legalise medicinal cannabis in Australia gain momentum. But do we have enough evidence on both its potential long-term adverse effects and the short-term health benefits to fully inform our decisions? I believe the answer to that question is no. That is why I am urging Australian governments at all levels to urgently invest in and support further research and clinical trials. The risks and benefits of medicinal cannabis should be weighed carefully, and its ingredients must be subjected to the same scrutiny as other medicines. The legalisation of medicinal cannabis is an emotionally charged issue with medical, legal, ethical and moral considerations. I, like every Australian, have been deeply affected by the stories of individuals searching for a treatment that will ease their suffering or improve their health. As a parent, I deeply sympathise with every parent's desire to do what is best for their child's health. After all, what is more important than our own health and that of our families? As a gastroenterologist, I want to be able to offer my patients suffering from severe and chronic pain the best and most effective treatment available. As a humanitarian, I believe we must show compassion to those in our community who are suffering from terminal or ill health. I am committed to " the needs of the patient come first", a principle so elegantly articulated by William J. Mayo, of Mayo Clinic fame, more than 100 years ago. My prevailing duty as a doctor is to base my clinical decisions on the best available evidence when treating my patients. The doctors' Hippocratic oath, " to first, do no harm" guides my conduct. I cannot let my heart rule my head. To do so would potentially compromise the health and safety of my patients. Now to the evidence. In the field of neurology, the most promising use of medicinal cannabis is in relation to treating spasticity and related pain. We also know that there are some limited benefits from marijuana and other cannabinoids to treat and relieve the symptoms for a number of clinical conditions. These include chronic pain, AIDS associated anorexia and wasting syndrome, multiple sclerosis, epilepsy and glaucoma. While some patients may experience relief from their symptoms, there is still insufficient data available on the effectiveness and safety of marijuana or other cannabinoids to treat these conditions. In light of all of this, many in the medical community remain concerned about the adverse health impacts of marijuana ( for example, dependence, repeated vomiting or psychosis), including when it is used for medicinal purposes. Dan L. Longo, MD and editor of The New England Journal of Medicine, summed up the current situation well: " We need to improve our understanding of how to harness the potential medical benefits of the marijuana plant without exposing people who are sick to its intrinsic risks." After comprehensively studying the evidence around the medicinal uses of cannabis and reviewing the benefits and risks associated with its use, a UK Royal College of Physicians' ( RCP) report concluded that while the active ingredient of cannabis, tetrahydrocannabinol ( THC), appears to provide some benefit in the treatment of certain illnesses, the RCP recommended further clinical trials. The results of some of these trials have not been definitive, which is why further research is needed. Let me be clear: I am a strong supporter of research that leads to effective medical treatments. However, until the processes of therapeutic goods regulation and the standards of evidence and clinical research produce clear and indisputable conclusions regarding the health impacts of medical marijuana, we must proceed with caution. - --- MAP posted-by: Jay Bergstrom